Patients With Terminal Blood Cancer Stress Need for Transfusion Access in Hospice Care, Survey Finds
Researchers surveyed patients with blood cancer regarding what they value as the most important service in their hospice care.
According to results from the IMerge trial, 2 39.8% of patients treated with imetelstat achieved 8 weeks of transfusion independence compared with 15.0% of patients treated with placebo. Respondents ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results